BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Komanduri S, Muthusamy VR, Wani S. Controversies in Endoscopic Eradication Therapy for Barrett’s Esophagus. Gastroenterology 2018;154:1861-1875.e1. [DOI: 10.1053/j.gastro.2017.12.045] [Cited by in Crossref: 10] [Cited by in F6Publishing: 7] [Article Influence: 2.5] [Reference Citation Analysis]
Number Citing Articles
1 Cholapranee A, Trindade AJ. Challenges in Endoscopic Therapy of Dysplastic Barrett's Esophagus. Curr Treat Options Gastroenterol 2019;17:32-47. [PMID: 30663018 DOI: 10.1007/s11938-019-00215-8] [Reference Citation Analysis]
2 Wu H, Minamide T, Yano T. Role of photodynamic therapy in the treatment of esophageal cancer. Dig Endosc 2019;31:508-16. [PMID: 30667112 DOI: 10.1111/den.13353] [Cited by in Crossref: 29] [Cited by in F6Publishing: 25] [Article Influence: 9.7] [Reference Citation Analysis]
3 Panda A, Shin MR, Cheng C, Bajpai M. Barrett's Epithelium to Esophageal Adenocarcinoma: Is There a "Point of No Return"? Front Genet 2021;12:706706. [PMID: 34603373 DOI: 10.3389/fgene.2021.706706] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
4 Bowman CJ, Zhang R, Balitzer D, Wang D, Rabinovitch PS, Kővári BP, Mattis AN, Kakar S, Lauwers GY, Choi WT. Persistent or recurrent Barrett's neoplasia after an endoscopic therapy session is associated with DNA content abnormality and can be detected by DNA flow cytometric analysis of paraffin-embedded tissue. Mod Pathol 2021. [PMID: 34108638 DOI: 10.1038/s41379-021-00832-8] [Reference Citation Analysis]
5 Krause J, Rösch T, Steurer S, Clauditz T, Sehner S, Schumacher U, Neuhaus H, Messmann H, Schumacher B, Probst A, Schachschal G, Ehlken H, Vieth M, Schmitz R. Quantitative analysis of submucosal excision depth in endoscopic resection for early Barrett's cancer. Endoscopy 2021. [PMID: 34856621 DOI: 10.1055/a-1659-3514] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
6 Bergman JJ, Yachimski PS. Advances in Endoscopic Therapy. Gastroenterology 2018;154:1859-60. [PMID: 29653148 DOI: 10.1053/j.gastro.2018.04.007] [Reference Citation Analysis]
7 Wronska E, Polkowski M, Orlowska J, Mroz A, Wieszczy P, Regula J. Argon plasma coagulation for Barrett's esophagus with low-grade dysplasia: a randomized trial with long-term follow-up on the impact of power setting and proton pump inhibitor dose. Endoscopy 2021;53:123-32. [PMID: 32650347 DOI: 10.1055/a-1203-5930] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 2.5] [Reference Citation Analysis]
8 Porter RJ, Murray GI, Brice DP, Petty RD, McLean MH. Novel biomarkers for risk stratification of Barrett's oesophagus associated neoplastic progression-epithelial HMGB1 expression and stromal lymphocytic phenotype. Br J Cancer 2020;122:545-54. [PMID: 31831860 DOI: 10.1038/s41416-019-0685-1] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 1.3] [Reference Citation Analysis]
9 Condon A, Muthusamy VR. The evolution of endoscopic therapy for Barrett's esophagus. Ther Adv Gastrointest Endosc 2021;14:26317745211051834. [PMID: 34708204 DOI: 10.1177/26317745211051834] [Reference Citation Analysis]
10 Choi WT, Lauwers GY, Montgomery EA. Utility of ancillary studies in the diagnosis and risk assessment of Barrett's esophagus and dysplasia. Mod Pathol 2022. [PMID: 35260826 DOI: 10.1038/s41379-022-01056-0] [Reference Citation Analysis]
11 Siddiki HA, Lam-himlin DM, Kahn A, Bandres MV, Burdick GE, Crowell MD, Pannala R, Ramirez FC, Vela MF, Fleischer DE. Intestinal metaplasia of the gastric cardia: findings in patients with versus without Barrett’s esophagus. Gastrointestinal Endoscopy 2019;89:759-68. [DOI: 10.1016/j.gie.2018.10.048] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 2.0] [Reference Citation Analysis]
12 Rouphael C, Anil Kumar M, Sanaka MR, Thota PN. Indications, contraindications and limitations of endoscopic therapy for Barrett's esophagus and early esophageal adenocarcinoma. Therap Adv Gastroenterol 2020;13:1756284820924209. [PMID: 32523628 DOI: 10.1177/1756284820924209] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]